×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
AAPG – ascentage pharma group international - american depository shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
AAPG
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/4
07:00 pm
aapg
Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA
Neutral
Report
Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA
12/4
07:04 am
aapg
Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
Medium
Report
Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating on the stock.
12/1
08:00 am
aapg
Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
Neutral
Report
Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
11/24
07:00 pm
aapg
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy
Low
Report
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Nature’s Signal Transduction and Targeted Therapy
11/24
09:04 am
aapg
Ascentage Pharma Group International (NASDAQ:AAPG) was given a new $51.00 price target on by analysts at Truist Financial Corporation.
Medium
Report
Ascentage Pharma Group International (NASDAQ:AAPG) was given a new $51.00 price target on by analysts at Truist Financial Corporation.
11/24
08:43 am
aapg
Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
Medium
Report
Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
11/19
08:00 am
aapg
Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025
Low
Report
Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025
11/10
08:03 am
aapg
Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at BTIG Research. They set a "buy" rating and a $50.00 price target on the stock.
Low
Report
Ascentage Pharma Group International (NASDAQ:AAPG) is now covered by analysts at BTIG Research. They set a "buy" rating and a $50.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: